Pancreatic Cancer in Hereditary Pancreatitis: Consensus Guidelines for Prevention, Screening and Treatment
References (60)
- et al.
AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adeno-carcinoma
American Gastroenterological Association. Gastroenterology
(1999) Hereditary pancreatitis:
Historical perspectives. Med Clin North Am
(2000)- et al.
Hereditary pancreatitis: Epidemiology, molecules, mutations, and models
J Lab Clin Med
(2000) - et al.
Genetic testing for hereditary pancreatitis: Guidelines for indications, counselling, consent and privacy issues
Pancreatology
(2001) - et al.
Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis
Gastroenterology
(1997) - et al.
Hereditary pancreatitis in North America:
The Pittsburgh-Midwest Multi-Center Pancreatic Study Group study. Pan-creatology
(2001) - et al.
Hereditary pancreatitis in Japan:
A review of pancreatitis-associated gene mutations. Pancreatology
(2001) - et al.
Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen
Biochem Biophys Res Commun
(2000) Human cationic trypsinogen:
Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem
(2000)- et al.
Comparative in vitro studies on native and recombinant human cationic trypsins:
Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. J Biol Chem
(2001)
The pathobiochemistry of hereditary pancreatitis:
Studies on recombinant human cationic trypsinogen. Pancreatology
A signal peptide cleavage site mutation in the cationic trypsino-gen gene is strongly associated with chronic pancreatitis
Gastroenterology
Trypsinogen mutations in chronic pancreatitis
Gastroenterol-ogy
The A16V signal peptide cleavage site mutation in the cat-ionic trypsinogen gene and chronic pancreatitis
Gastroenterology
Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation
Gastroenterology
Gene-environment interactions in pancreatic cancer
Pancreatology
Molecular genetic alterations in ductal pancreatic adenocarcinomas
Med Clin North Am
Growth factors, receptors, and molecular alterations in pancreatic cancer:
Putting it all together. Med Clin North Am
Pancreatic cancer: Factors regulating tumor development, maintenance and metastasis
Pancreatology
Risk factors for cancer in hereditary pancreatitis
International Hereditary Pancreatitis Study Group. Med Clin North Am
Preventive strategies and therapeutic options for hereditary pancreatitis
Med Clin North Am
Recurrent acute pancreatitis:
An algorithmic approach to identification and elimination of inciting factors. Gastroenterology
Chronic pancreatitis: Diagnosis, classification, and new genetic developments
Gastroenterology
A multispeciality approach to the diagnosis and management of pancreatic cancer
Am J Gastroenterol
Pancreatic cancer surveillance in a high risk cohort: Is it worth the cost?
Med Clin North Am
Endoscopic ultrasound in pancreatic diseases
Gastroenterol Clin North Am
Role of EUS in the preoperative staging of pancreatic cancer:
A large single-center experience. Gastrointest En-dosc
Role of EUS in the evaluation of pancreatic adenocarcinoma
Gastrointest Endosc
MR imaging of pancreatic masses
Magn Reson Imaging Clin N Am
Pancreatic cancer detection with magnetic resonance cholangio-pancreatography and endoscopic retrograde cholangiopancreatography:
A prospective controlled study. Lancet
Cited by (81)
Carcinoma of the Pancreas
2019, Abeloff’s Clinical OncologyCurrent Approaches to Pancreatic Cancer Screening
2019, American Journal of PathologyCitation Excerpt :The CAPS Consortium recommends screening for familial PDAC beginning at the age of 50 years.44 However, most programs have initiated screening at the age of 40 years, or 10 years before the youngest age of onset for PRSS1 mutation carriers with HP,54 and at the age of 30 years among patients with PJ syndrome, given the younger ages of onset in this high-risk subset. PDAC lesions can be detected through various imaging modalities.
Familial Pancreatic Ductal Adenocarcinoma
2019, American Journal of PathologyThe Role of Genetics in Pancreatitis
2018, Gastrointestinal Endoscopy Clinics of North AmericaImaging and Screening of Pancreatic Cancer
2017, Radiologic Clinics of North AmericaCitation Excerpt :Hereditary tumor predisposition syndromes include Peutz-Jeghers syndrome, familial atypical multiple mole melanoma, hereditary breast-ovarian cancer, hereditary nonpolyposis colorectal carcinoma, and familial adenomatous polyposis.38 Associated gene mutations, risk of PDAC development, and screening recommendations are summarized in Table 2.4,39–46 Syndromes with chronic inflammation of the pancreas includes hereditary pancreatitis and cystic fibrosis.
Pancreatic cancer screening: Still a delusion?
2017, Pancreatology